Short-term effectiveness of the XBB.1.5 updated COVID-19 vaccine against hospitalisation in Denmark: a national cohort study

Affiliations

¹ Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Artillerivej 5, 2300 Kbh S, Denmark; MRC International Statistics and Epidemiology Group, London School of Hygiene and Tropical Medicine, London, UK. Electronic address: choh@ssi.dk.
² Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Artillerivej 5, 2300 Kbh S, Denmark.
³ Virus Research and Development Laboratory, Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
⁴ Division of Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark.

Christian Holm Hansen et al. Lancet Infect Dis. 2024 Feb.

. 2024 Feb;24(2):e73-e74.

doi: 10.1016/S1473-3099(23)00746-6. Epub 2024 Jan 5.

¹ Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Artillerivej 5, 2300 Kbh S, Denmark; MRC International Statistics and Epidemiology Group, London School of Hygiene and Tropical Medicine, London, UK. Electronic address: choh@ssi.dk.
² Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Artillerivej 5, 2300 Kbh S, Denmark.
³ Virus Research and Development Laboratory, Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
⁴ Division of Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark.

No abstract available

Conflict of interest statement

We declare no competing interests.